|
Delayed
Nasdaq Stockholm
04:00:00 28/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 2.020 SEK | +3.80% |
|
-2.18% | +2.54% |
| 10:21pm | Irlab Therapeutics Set to Obtain US Patent for Parkinson's Disease Drug Candidate | MT |
| 05:04pm | Irlab receives positive patent notice in the US for IRL1117 | FW |
| Market Cap | 289M 29.07M 25.99M 24.05M 21.77M 40.75M 2.77B 41.42M 114M 1.45B 109M 107M 4.58B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 289M 29.07M 25.99M 24.05M 21.77M 40.75M 2.77B 41.42M 114M 1.45B 109M 107M 4.58B | EV / Sales 2026 * |
2.86x | EV / Sales 2027 * | 2.02x |
| Free-Float |
83.4% | Yield 2026 * |
-
| Yield 2027 * | - |
Nasdaq StockholmSEK
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| IRLAB A | Delayed | |
Deutsche Boerse AG
| 6IRA | Delayed | |
|
OTC Markets
| IRLAF | Delayed |
| 1 day | +3.80% | ||
| 1 week | -2.18% | ||
| Current month | +10.62% | ||
| 1 month | +7.10% | ||
| 3 months | +62.12% | ||
| 6 months | +31.34% | ||
| Current year | +2.54% |
| 1 week | 1.86 |  | 2.09 |
| 1 month | 1.7 | | 2.09 |
| Current year | 1.17 | | 2.14 |
| 1 year | 1.17 | | 2.78 |
| 3 years | 1.17 | | 20.2 |
| 5 years | 1.17 | | 51.5 |
| 10 years | 1.17 | | 110 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 63 | 01/08/2024 | |
Susanna Waters
PRN | Corporate Officer/Principal | 60 | 01/01/2013 |
Clas Sonesson
CTO | Chief Tech/Sci/R&D Officer | 65 | 01/01/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Rein Piir
BRD | Director/Board Member | 68 | 01/01/2016 |
| Chairman | 73 | 07/05/2020 | |
Veronica Wallin
BRD | Director/Board Member | 40 | 01/01/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/7/26 | Buy | Chairman | 31,000 | 38.8588% | ||
| 1/7/26 | Buy | Chief Technology Officer | 4,016,742 | - | ||
| 1/7/26 | Buy | Chief Executive Officer | 183,858 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.80% | -2.18% | -17.21% | -70.72% | 29.07M | |
| +0.33% | -0.23% | +54.98% | +128.61% | 1,140B | |
| +0.47% | +3.01% | +40.40% | +83.50% | 641B | |
| +0.01% | -0.96% | +25.56% | +106.09% | 507B | |
| +0.63% | +2.33% | +49.21% | +67.82% | 383B | |
| +1.00% | -4.17% | +61.49% | +38.21% | 347B | |
| +1.02% | +1.80% | +24.84% | +53.75% | 293B | |
| -0.25% | +1.62% | +2.20% | +26.65% | 266B | |
| +0.77% | +1.87% | +53.57% | +70.94% | 240B | |
| -0.41% | +0.91% | +31.09% | +106.12% | 197B | |
| Average | +0.69% | +2.45% | +32.61% | +61.10% | 401.38B | |
| Weighted average by Cap. | +0.36% | +2.98% | +41.99% | +88.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 101M 10.17M 9.09M 8.41M 7.61M 14.25M 967M 14.48M 40.03M 506M 38.15M 37.34M 1.6B | 143M 14.38M 12.86M 11.9M 10.77M 20.17M 1.37B 20.5M 56.64M 716M 53.99M 52.83M 2.27B |
| Net income | -36.1M -3.63M -3.24M -3M -2.72M -5.08M -345M -5.17M -14.28M -180M -13.61M -13.32M -571M | 34.6M 3.48M 3.11M 2.88M 2.6M 4.87M 331M 4.95M 13.69M 173M 13.04M 12.77M 548M |
| Net Debt | - | - |
Employees
31
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/10/26 | SEK 2.020 | +3.80% | 828,197 |
| 26/10/26 | SEK 1.946 | +0.93% | 730,010 |
| 23/10/26 | SEK 1.928 | -2.72% | 621,231 |
| 22/10/26 | SEK 1.982 | -4.48% | 638,431 |
| 21/10/26 | SEK 2.075 | +0.48% | 421,941 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- IRLAB A Stock
Select your edition
All financial news and data tailored to specific country editions
